Related Experiment Video
Updated: Jun 22, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Can parents accurately screen children at risk of developmental delay?
Glenys Dixon1, Nadia Badawi, Davina French
1Telethon Institute for Child Health Research, Centre for Child Health Research, The University of Western Australia, Subiaco, Western Australia. glenysd@ichr.uwa.edu.au
Insights
The Infant/Child Monitoring Questionnaire (IMQ) effectively screens high-risk infants for developmental delay. However, its low sensitivity in the general population suggests caution for widespread screening.
Area of Science:
- Developmental Pediatrics
- Neonatal Neurology
- Screening Tool Validation
Background:
- Developmental delay affects a significant number of infants, necessitating reliable early screening methods.
- High-risk populations, such as those with newborn encephalopathy (NE), require accurate tools to identify potential developmental issues.
- The Infant/Child Monitoring Questionnaire (IMQ) is a parent-completed tool proposed for developmental screening.
Purpose of the Study:
- To assess the validity and utility of the parent-completed Infant/Child Monitoring Questionnaire (IMQ) for screening developmental delay in high-risk infants.
- To compare the IMQ's performance against a standardized developmental assessment in a cohort of infants with and without high-risk factors.
Main Methods:
- One hundred forty-one term infants with moderate to severe newborn encephalopathy (NE) and 374 comparison infants underwent concurrent Griffiths Mental Development Scales (GMDS) assessment and IMQ.
- Key performance metrics including agreement, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated.
- Concordance between IMQ classifications and GMDS assessments was analyzed across different age groups.
Main Results:
- For infants with NE, the IMQ demonstrated high sensitivity (87%) and negative predictive value (97%), with a positive predictive value of 57%.
- In the comparison group, IMQ sensitivity was lower (50%), though specificity (94%) and negative predictive value (99%) remained high.
- Under-referral rates were 13% for infants with NE versus 50% for comparison infants.
Conclusions:
- The IMQ is supported as an accurate screening measure for infants identified as 'at risk' for developmental delay.
- Caution is advised regarding the IMQ's application for general population screening due to its lower sensitivity in non-high-risk infants.
- The findings highlight the IMQ's potential value in targeted screening programs for vulnerable infant populations.
Aim:
To evaluate the validity and potential value of the parent-completed Infant/Child Monitoring Questionnaire (IMQ) as a screening measure for developmental delay in high-risk infants.
Methods:
One hundred and forty-one term infants born with moderate or severe newborn encephalopathy (NE) and 374 randomly selected comparison infants were administered a Griffiths Mental Development Scales (GMDS) assessment and an IMQ concurrently. Concordance of classifications between measures was compared for agreement, sensitivity, specificity, positive predictive value, negative predictive value, false positives and false negatives.
Results:
Overall, sensitivity and specificity of the IMQ for infants with NE averaged across all age groups was 87%, positive predictive value 57% and negative predictive value 97%. The IMQ did not perform as well for comparison infants with a sensitivity of 50%, specificity 94%, positive predictive value 15% and negative predictive value 99% averaged across all age groups. Overall under-referral for infants with NE was 13%, compared with 50% for comparison infants.
Conclusions:
Use of the IMQ as an accurate screening measure in infants 'at risk' of developmental delay is supported. The low sensitivity of the IMQ for the comparison infants indicates a need for caution when considering its application for general population screening.
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Introduction to Developmental Psychology

